Abstract: The present invention is directed to a nucleic acid suitable for use in treatment or prophylaxis of an infection with a coronavirus, preferably with a Coronavirus SARS-CoV-2, or a disorder related to such an infection, preferably COVID-19. The present invention is also directed to compositions, polypeptides, and vaccines. The compositions and vaccines preferably comprise at least one of said nucleic acid sequences, preferably nucleic acid sequences in association a lipid nanoparticle (LNP). The invention is also directed to first and second medical uses of the nucleic acid, the composition, the polypeptide, the combination, the vaccine, and the kit, and to methods of treating or preventing a coronavirus infection, preferably a Coronavirus infection.

Abstract: A device for processing drinks closure caps having at least one cutting unit with at least one cutting blade and a detection unit which, in turn, has a camera as well as at least one conveying device forming a transport path to and from the cutting unit is disclosed. In order to solve the problems of known devices, the detection unit has an optical system and is arranged operatively downstream of the cutting unit such that it fully captures the inner wall of a drinks closure cap located in its field of vision.

Abstract: A device for processing drinks closure caps having at least one cutting unit with at least one cutting blade and a detection unit which, in turn, has a camera as well as at least one conveying device forming a transport path to and from the cutting unit is disclosed. In order to solve the problems of known devices, the detection unit has an optical system and is arranged operatively downstream of the cutting unit such that it fully captures the inner wall of a drinks closure cap located in its field of vision.